OrbiMed’s Inspire Medical Systems INSP Stock Holding History

OrbiMed’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-347,000	Closed	-$30.2M	–	153
2020 Q2	$30.2M	Hold	347,000	–	–	0.43%	65
2020 Q1	$20.9M	Sell	347,000 -1,000,000	-74%	-$74M	0.35%	64
2019 Q4	$100M	Sell	1,347,000 -124,000	-8%	-$7.97M	1.43%	22
2019 Q3	$89.8M	Hold	1,471,000	–	–	1.7%	18
2019 Q2	$89.2M	Hold	1,471,000	–	–	1.38%	20
2019 Q1	$83.5M	Sell	1,471,000 -358,449	-20%	-$19.4M	1.29%	23
2018 Q4	$77.3M	Sell	1,829,449 -614,772	-25%	-$26.1M	1.43%	20
2018 Q3	$103M	Hold	2,444,221	–	–	1.24%	24
2018 Q2	$87.2M	Buy	+2,444,221	New	+$78.9M	1.04%	33

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

OrbiMed's INSP Position: Q3 2020 in Review

OrbiMed sold out of Inspire Medical Systems (INSP) in Q3 2020, closing a stake of 347,000 shares — an estimated $30.2M sold.

OrbiMed first reported a position in INSP in Q2 2018 and held it in 9 quarters. The position peaked at $103M in Q3 2018. 204 funds tracked by Wall St. Rank hold INSP as of Q3 2020.

OrbiMed reported no remaining Inspire Medical Systems position as of Q3 2020 after selling out during the quarter.
OrbiMed sold 347,000 Inspire Medical Systems shares in Q3 2020, an estimated $30.2M.
OrbiMed first reported a position in Inspire Medical Systems in Q2 2018 and held it in 9 quarters.
OrbiMed's Inspire Medical Systems position peaked at $103M in Q3 2018.
204 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2020.

Based on OrbiMed's 13F filing for Q3 2020, filed 16 Nov 2020.